Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-TFG Antibody (R2M60)

Catalog #:   RHK59701 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: IHC, IP, WB
Accession: Q92734
Overview

Catalog No.

RHK59701

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

IHC: 1:50-1:100, IP: 1:20, WB: 1:500-1:1000

Target

Protein TFG, TRK-fused gene protein, TFG

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q92734

Applications

IHC, IP, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R2M60

Data Image
  • Immunohistochemical
    Immunohistochemistry analysis of paraffin-embedded Human tonsil using TRK fused gene antibody.High-pressure and temperature Sodium Citrate pH 6.0 was used for antigen retrieval.
  • Western blot
    Western blot analysis of TRK fused gene in K562, rat Brain, C6, 3T3, Hela lysates using TFG antibody.
References

Targeting molecular pathways to control immune checkpoint inhibitor toxicities., PMID:39732529

Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours., PMID:39663448

Biosimilar monoclonal antibodies for cancer treatment in adults., PMID:39607013

Batf3+ DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy., PMID:38656869

Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses., PMID:38623463

Immunogenic epitope scanning in bacteriolytic enzymes Pal and Cpl-1 and engineering Pal to escape antibody responses., PMID:37781366

Design and investigation of targeting agent orientation and density on nanoparticles for enhancing cellular uptake efficiency., PMID:37565424

Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas., PMID:37385724

Germline immunomodulatory expression quantitative trait loci (ieQTLs) associated with immune-related toxicity from checkpoint inhibition., PMID:37301715

Changes in TFG gene expression in bovine leucocytes transformed by Theileria annulata., PMID:36337204

Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies., PMID:35732350

Molecular Characterization of Inflammatory Tumors Facilitates Initiation of Effective Therapy., PMID:34814185

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma., PMID:34518290

TFG binds LC3C to regulate ULK1 localization and autophagosome formation., PMID:33932238

Preeclampsia: Cardiotonic Steroids, Fibrosis, Fli1 and Hint to Carcinogenesis., PMID:33669287

Primary hypothyroidism and autoimmune thyroiditis alter the transcriptional activity of genes regulating neurogenesis in the blood of patients., PMID:33600668

Tie2-mediated vascular remodeling by ferritin-based protein C nanoparticles confers antitumor and anti-metastatic activities., PMID:32928251

TFG is required for autophagy flux and to prevent endoplasmic reticulum stress in CH12 B lymphoma cells., PMID:32910713

Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy)., PMID:32894202

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19., PMID:32300051

A case of dual-mechanism immune-related anaemia in a patient with metastatic melanoma treated with nivolumab and ipilimumab., PMID:32169870

Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma., PMID:31703593

Muscle pathology of hereditary motor and sensory neuropathy with proximal dominant involvement with TFG mutation., PMID:31449671

Spatial and temporal immunoreactivity in the rat brain using an affinity purified polyclonal antibody to DNSP-11., PMID:31394198

Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma., PMID:30894212

Rapid Growth and Early Metastasis of Papillary Thyroid Carcinoma in an Adolescent Girl with Graves' Disease., PMID:30092570

Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab., PMID:30012206

Proteomic analysis identifies NPTX1 and HIP1R as potential targets of histone deacetylase-3-mediated neurodegeneration., PMID:29486577

A novel immunosensor based on excessively tilted fiber grating coated with gold nanospheres improves the detection limit of Newcastle disease virus., PMID:28888179

Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis., PMID:28356511

Human heart failure biomarker immunosensor based on excessively tilted fiber gratings., PMID:28101401

Label-free immunoassay for porcine circovirus type 2 based on excessively tilted fiber grating modified with staphylococcal protein A., PMID:27518582

Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors., PMID:25612511

TFG clusters COPII-coated transport carriers and promotes early secretory pathway organization., PMID:25586378

Immunohistochemical Localization of an Isoform of TRK-Fused Gene-Like Protein in the Rat Retina., PMID:25221366

Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial., PMID:24852116

Evidence of TRK-Fused Gene (TFG1) function in the ubiquitin-proteasome system., PMID:24613659

Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis., PMID:23266894

Transforming growth factor-β neutralizing antibodies inhibit subretinal fibrosis in a mouse model., PMID:22773978

Immunohistochemical Mapping of TRK-Fused Gene Products in the Rat Brainstem., PMID:22489105

Expression and Localization of TRK-Fused Gene Products in the Rat Brain and Retina., PMID:22489101

New advances in the treatment of gout: review of pegloticase., PMID:21127695

Suppression of murine SLE by oral anti-CD3: inducible CD4+CD25-LAP+ regulatory T cells control the expansion of IL-17+ follicular helper T cells., PMID:19433458

[Effect of nebulized TFG on Th1/Th2 imbalance in mouse model with asthma]., PMID:19007018

Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells., PMID:18941193

Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration., PMID:18688035

[Morphological tumor front grading and matrix metalloproteinases type I expression as a prognostic parameter of the presence of lymph node micrometastases in laryngeal carcinoma]., PMID:18552024

Early administration of abciximab bolus in the emergency department improves angiographic outcome after primary PCI as assessed by TIMI frame count: results of the early ReoPro administration in myocardial infarction (ERAMI) trial., PMID:16817177

Serum TGF-beta1 correlates with chronic histopathological lesions in protocol biopsies of kidney allograft recipients., PMID:15848527

Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion., PMID:15165915

Datasheet

Document Download

Anti-TFG Antibody (R2M60).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-TFG Antibody (R2M60) [RHK59701]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only